Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 214

1.

miR-223 promotes regenerative myeloid cell phenotype and function in the demyelinated central nervous system.

Galloway DA, Blandford SN, Berry T, Williams JB, Stefanelli M, Ploughman M, Moore CS.

Glia. 2018 Dec 11. doi: 10.1002/glia.23576. [Epub ahead of print]

PMID:
30548333
2.

Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status.

Mugo NR, Eckert L, Magaret AS, Cheng A, Mwaniki L, Ngure K, Celum C, Baeten JM, Galloway DA, Wamalwa D, Wald A.

Vaccine. 2018 Nov 12;36(46):7025-7032. doi: 10.1016/j.vaccine.2018.09.059. Epub 2018 Oct 5.

PMID:
30297124
3.

The roles of extracellular vesicle microRNAs in the central nervous system.

Blandford SN, Galloway DA, Moore CS.

Glia. 2018 Nov;66(11):2267-2278. doi: 10.1002/glia.23445. Epub 2018 May 4. Review.

PMID:
29726599
4.

Analysis of Memory B-Cell Responses Reveals Suboptimal Dosing Schedule of a Licensed Vaccine.

Scherer EM, Smith RA, Carter JJ, Wipf GC, Gallego DF, Stern M, Wald A, Galloway DA.

J Infect Dis. 2018 Jan 30;217(4):572-580. doi: 10.1093/infdis/jix566.

5.

High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.

Wallace NA, Khanal S, Robinson KL, Wendel SO, Messer JJ, Galloway DA.

J Virol. 2017 Sep 27;91(20). pii: e01084-17. doi: 10.1128/JVI.01084-17. Print 2017 Oct 15.

6.

Effects of fumarates on inflammatory human astrocyte responses and oligodendrocyte differentiation.

Galloway DA, Williams JB, Moore CS.

Ann Clin Transl Neurol. 2017 May 4;4(6):381-391. doi: 10.1002/acn3.414. eCollection 2017 Jun.

7.

Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.

Fu Xi L, Schiffman M, Ke Y, Hughes JP, Galloway DA, He Z, Hulbert A, Winer RL, Koutsky LA, Kiviat NB.

Int J Cancer. 2017 Apr 15;140(8):1747-1756. doi: 10.1002/ijc.30594. Epub 2017 Jan 24.

8.

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study.

Paulson KG, Lewis CW, Redman MW, Simonson WT, Lisberg A, Ritter D, Morishima C, Hutchinson K, Mudgistratova L, Blom A, Iyer J, Moshiri AS, Tarabadkar ES, Carter JJ, Bhatia S, Kawasumi M, Galloway DA, Wener MH, Nghiem P.

Cancer. 2017 Apr 15;123(8):1464-1474. doi: 10.1002/cncr.30475. Epub 2016 Dec 7.

9.

Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.

Jardine JG, Sok D, Julien JP, Briney B, Sarkar A, Liang CH, Scherer EM, Henry Dunand CJ, Adachi Y, Diwanji D, Hsueh J, Jones M, Kalyuzhniy O, Kubitz M, Spencer S, Pauthner M, Saye-Francisco KL, Sesterhenn F, Wilson PC, Galloway DA, Stanfield RL, Wilson IA, Burton DR, Schief WR.

PLoS Pathog. 2016 Sep 14;12(9):e1005905. doi: 10.1371/journal.ppat.1005905. eCollection 2016 Sep.

10.

Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.

Fu TC, Carter JJ, Hughes JP, Feng Q, Hawes SE, Schwartz SM, Xi LF, Lasof T, Stern JE, Galloway DA, Koutsky LA, Winer RL.

Int J Cancer. 2016 Nov 15;139(10):2201-12. doi: 10.1002/ijc.30283. Epub 2016 Aug 4.

11.

A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects.

Scherer EM, Smith RA, Gallego DF, Carter JJ, Wipf GC, Hoyos M, Stern M, Thurston T, Trinklein ND, Wald A, Galloway DA.

EBioMedicine. 2016 Aug;10:55-64. doi: 10.1016/j.ebiom.2016.06.042. Epub 2016 Jun 29.

12.

miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation.

Galloway DA, Moore CS.

Front Cell Dev Biol. 2016 Jun 17;4:59. doi: 10.3389/fcell.2016.00059. eCollection 2016. Review.

13.

The Murky Life of Merkel Cell Polyomavirus.

Galloway DA.

Cell Host Microbe. 2016 Jun 8;19(6):747-8. doi: 10.1016/j.chom.2016.05.021.

14.

Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case-control study.

Colombara DV, Manhart LE, Carter JJ, Hawes SE, Weiss NS, Hughes JP, Qiao YL, Taylor PR, Smith JS, Galloway DA.

BMC Cancer. 2016 Jun 1;16:342. doi: 10.1186/s12885-016-2381-3.

15.

Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3).

Madeleine MM, Johnson LG, Doody DR, Tipton ER, Carter JJ, Galloway DA.

J Low Genit Tract Dis. 2016 Jul;20(3):257-60. doi: 10.1097/LGT.0000000000000227.

16.

Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia.

Xi LF, Schiffman M, Koutsky LA, Hughes JP, Hulbert A, Shen Z, Galloway DA, Kiviat NB.

Int J Cancer. 2016 Sep 1;139(5):1098-105. doi: 10.1002/ijc.30164. Epub 2016 May 14.

17.

Novel Functions of the Human Papillomavirus E6 Oncoproteins.

Wallace NA, Galloway DA.

Annu Rev Virol. 2015 Nov;2(1):403-23. doi: 10.1146/annurev-virology-100114-055021. Epub 2015 Sep 2. Review.

PMID:
26958922
18.

Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women.

Sadate-Ngatchou P, Carter JJ, Hawes SE, Feng Q, Lasof T, Stern JE, Fu TC, Galloway DA, Koutsky LA, Winer RL.

Sex Transm Dis. 2016 Mar;43(3):192-8. doi: 10.1097/OLQ.0000000000000409.

19.

Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control study.

Colombara DV, Manhart LE, Carter JJ, Hawes SE, Weiss NS, Hughes JP, Barnett MJ, Goodman GE, Smith JS, Qiao YL, Galloway DA.

Cancer Causes Control. 2015 Dec;26(12):1835-44. doi: 10.1007/s10552-015-0676-3. Epub 2015 Sep 28.

20.

Human papillomaviruses: shared and distinct pathways for pathogenesis.

Galloway DA, Laimins LA.

Curr Opin Virol. 2015 Oct;14:87-92. doi: 10.1016/j.coviro.2015.09.001. Epub 2015 Sep 20. Review.

Supplemental Content

Loading ...
Support Center